Chromatographic and electrophoretic assessment of Filgrastim biosimilars in pharmaceutical formulations.

[1]  G. Laible,et al.  Coupled solid phase extraction and microparticle-based stability and purity-indicating immunosensor for the determination of recombinant human myelin basic protein in transgenic milk. , 2013, Talanta.

[2]  K. Ganzler,et al.  Analytical aspects of biosimilarity issues of protein drugs. , 2012, Journal of pharmaceutical and biomedical analysis.

[3]  G. Laible,et al.  CZE with On-line Micellar Sample Stacking for Determination of Protein Concentration of Biopharmaceuticals , 2011 .

[4]  F. Sörgel,et al.  Physicochemical and Biologic Comparability of a Biosimilar Granulocyte Colony-Stimulating Factor with its Reference Product , 2010, BioDrugs.

[5]  A. Škrlin,et al.  Correlation of liquid chromatographic and biological assay for potency assessment of filgrastim and related impurities. , 2010, Journal of pharmaceutical and biomedical analysis.

[6]  A. Škrlin,et al.  Comparison of the physicochemical properties of a biosimilar filgrastim with those of reference filgrastim. , 2010, Biologicals : journal of the International Association of Biological Standardization.

[7]  G. Laible,et al.  Probing the interaction between recombinant human myelin basic protein and caseins using surface plasmon resonance and diffusing wave spectroscopy , 2009, Journal of molecular recognition : JMR.

[8]  G. Laible,et al.  On-line casein micelle disruption for downstream purification of recombinant human myelin basic protein produced in the milk of transgenic cows. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  M. Al-Ghobashy,et al.  Factors Affecting the Performance of Capillary Isoelectric Focusing in Dynamically Coated Capillaries Using Polyethylene Oxide Polymer , 2008 .

[10]  M. Iwakura,et al.  A Systematic and Comprehensive Combinatorial Approach to Simultaneously Improve the Activity, Reaction Specificity, and Thermal Stability of p-Hydroxybenzoate Hydroxylase* , 2007, Journal of Biological Chemistry.

[11]  S. Dalmora,et al.  Validation of an RP‐LC Method and Assessment of rhG‐CSF in Pharmaceutical Formulations by Liquid Chromatography and Biological Assay , 2006 .

[12]  G. Luo,et al.  Characterization of recombinant human granulocyte colony stimulating factor (rHuG-CSF) by capillary zone electrophoresis, capillary isoelectric focusing electrophoresis and electrospray ionization mass spectrometry. , 2004, Journal of pharmaceutical and biomedical analysis.

[13]  W. Stites,et al.  Comparing the effect on protein stability of methionine oxidation versus mutagenesis: steps toward engineering oxidative resistance in proteins. , 2001, Protein engineering.

[14]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[15]  D. Niederwieser,et al.  The challenge of biosimilars. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  Daniel I. C. Wang,et al.  Effects of Excipients on the Hydrogen Peroxide-Induced Oxidation of Methionine Residues in Granulocyte Colony-Stimulating Factor , 2004, Pharmaceutical Research.

[17]  L. Sharaf,et al.  Filgrastim use: evaluation in cancer and critically ill non- cancer patients , 2003 .

[18]  T. Boone,et al.  Characterization, formulation, and stability of Neupogen (Filgrastim), a recombinant human granulocyte-colony stimulating factor. , 1996, Pharmaceutical biotechnology.

[19]  T. Pritchett.  Capillary isoelectric focusing of proteins , 1996, Electrophoresis.